Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-05-22

Clinical Trial Update: Real World Use of Lenacapavir, as an add-on to an Optimized Background Regimen in France

View source ↗

Summary

ClinicalTrials.gov update describes real-world use of lenacapavir as an add-on to an optimized background regimen for HIV-1 infection in France; the study is cu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lenacapavir (lenacapavir)

Snippet

Sponsor: Centre de Recherches et d'Etude sur la Pathologie Tropicale et le Sida | Conditions: HIV I Infection | Status: RECRUITING